AI assistant
Sending…
Clene Inc. — Director's Dealing 2021
May 19, 2021
34487_dirs_2021-05-18_f64d7d9d-3c3c-437d-a08d-c95189b40665.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2021-05-18
Reporting Person: MATLIN DAVID J (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-18 | Stock Options (Right to buy) | $8.59 | A | 30000.00 | Acquired | 2031-05-18 | Common Stock (30000.00) | Direct |
| 2021-05-18 | Stock Options (Right to buy) | $8.59 | A | 3358.00 | Acquired | 2031-05-18 | Common Stock (3358.00) | Direct |
Footnotes
F1: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested
F2: This option was granted on May18, 2021 as an option for 3,358 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.
More from Clene Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Mar 17
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20